TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive Going private may allow US Oncology to restructure, respond to Medicare cuts; equity investment firm offers to purchase shares. April 23, 2004